Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya, +22

The Lancet Oncology

Interim AnalysisOncologyBevacizumab Versus ErlotinibPathologyImmune Checkpoint Inhibitor +6

Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line

Akihiko Gemma, K. Takenaka, Yoko Hosoya, +10

European Journal of Cancer

Altered ExpressionMetastatic SubpopulationsTumor HeterogeneityMedicinePathology +9

Atrial natriuretic peptide distribution in fetal and failed adult human hearts.

Hidetsugu Tsuchimochi, Futoshi Kurimoto, Keiko Ieki, +5

Circulation

Cardiac MuscleRight AtriumHeart FailureImmunologyAnp Granules +16

Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers

Akihiko Gemma, Yoko Hosoya, Masahiro Seike, +7

Lung Cancer

Somatic VariantOncogenic AgentHuman Mad2 GeneGeneticsMedicine +7

Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer

Masahiro Ando, Kunihiko Kobayashi, Akinobu Yoshimura, +10

Lung Cancer

OncologyMedicineCancer ManagementWeekly AdministrationPharmacotherapy +4

Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis

Yoko Hosoya, Akihiko Gemma, Masahiro Seike, +6

Lung Cancer

Tumor BiologyDistant MetastasisMedicinePrimary Lung CancerPathology +8

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

Tatsuro Fukuhara, Haruhiro Saito, Naoki Furuya, +22

EBioMedicine

The promoter region of the human BUBR1 gene and its expression analysis in lung cancer

Masahiro Seike, Akihiko Gemma, Yoko Hosoya, +9

Lung Cancer

Human Bubr1 GenePromoter RegionOncogenic AgentMedicineGenetics +8

Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing

Gou Yamamoto, Mari Kikuchi, Shiho Kobayashi, +16

International Journal of Oncology

Genetic TestingNext GenerationRoutine Genetic TestingAdvanced Lung DiseaseMedicine +12

Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial

Hidehito Horinouchi, Kaoru Kubota, Akihiko Miyanaga, +12

ESMO Open